Terms: = Prostate cancer AND PRCC, Q92733, TPRC, RCCP1, MGC4723, MGC17178, ENSG00000143294, 5546
9 results:
1. Potential role of
Aggarwal P; Singh H; Das CK; Mavuduru RS; Kakkar N; Lal A; Gorsi U; Kumar R; Mittal BR
Eur J Radiol; 2024 Jan; 170():111218. PubMed ID: 38007857
[TBL] [Abstract] [Full Text] [Related]
2. Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and prcc from non-malignant renal cells in vitro.
Zieren RC; Dong L; Clark DJ; Kuczler MD; Horie K; Moreno LF; Lih TM; Schnaubelt M; Vermeulen L; Zhang H; de Reijke TM; Pienta KJ; Amend SR
Med Oncol; 2021 Jul; 38(9):105. PubMed ID: 34331598
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis.
Rosiello G; Palumbo C; Knipper S; Pecoraro A; Luzzago S; St-Hilaire PA; Tian Z; Capitanio U; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
World J Urol; 2021 Feb; 39(2):461-472. PubMed ID: 32253579
[TBL] [Abstract] [Full Text] [Related]
4. Development and internal validation of a novel model and markers to identify the candidates for lymph node metastasis in patients with prostate cancer.
Cao HM; Wan Z; Wu Y; Wang HY; Guan C
Medicine (Baltimore); 2019 Jul; 98(30):e16534. PubMed ID: 31348270
[TBL] [Abstract] [Full Text] [Related]
5. Association between human papillomavirus infection and prostate cancer: A global systematic review and meta-analysis.
Moghoofei M; Keshavarz M; Ghorbani S; Babaei F; Nahand JS; Tavakoli A; Mortazavi HS; Marjani A; Mostafaei S; Monavari SH
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e59-e67. PubMed ID: 30740893
[TBL] [Abstract] [Full Text] [Related]
6. The association of renal cell carcinoma with gastrointestinal stromal tumors.
Mendonca SJ; Sanchez A; Blum KA; Ghanaat M; Kashan MY; Benfante N; Russo P; Coleman JA; Crago AM; Hakimi AA
J Surg Oncol; 2018 Jun; 117(8):1716-1720. PubMed ID: 29878354
[TBL] [Abstract] [Full Text] [Related]
7. Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease.
Wagener N; Edelmann D; Benner A; Zigeuner R; Borgmann H; Wolff I; Krabbe LM; Musquera M; Dell'Oglio P; Capitanio U; Klatte T; Cindolo L; May M; Brookman-May SD;
PLoS One; 2017; 12(9):e0184173. PubMed ID: 28934212
[TBL] [Abstract] [Full Text] [Related]
8. Expression of prostate-specific membrane antigen in tumor-associated neovasculature of renal neoplasms.
Baccala A; Sercia L; Li J; Heston W; Zhou M
Urology; 2007 Aug; 70(2):385-90. PubMed ID: 17826525
[TBL] [Abstract] [Full Text] [Related]
9. [Heredity in renal and prostatic neoplasia].
Prayer Galetti T; D'Arrigo L; De Zorzi L; Patarnello T
Arch Ital Urol Androl; 1997 Sep; 69(4):241-6. PubMed ID: 9417296
[TBL] [Abstract] [Full Text] [Related]